African Female Breast Cancer Epidemiology (AFBRECANE) Study Project summary Breast cancer is the commonest cancer in women globally and it is increasingly overtaking cervical cancer as the commonest female cancer in low and middle income countries (LMIC). The incidence of breast cancer Nigeria was 54.3 per 100,000 per year (24,750 new cases per year) in 2014 representing a rise from 20 per 100,000 in the 1970s (3,000 new cases per year).
Understanding microbial shifts and how they affect vaccine response is central to this study. We will determine if gut microbial communities associated with breastfeeding in the HEU infant follows the same successional trajectory as HU controls and resolve the differences at functional level. How the continuous conditioning of the infant gut by the microbiota from the breast milk affects the infant microbiome and subsequent
Overall Recent viral outbreaks in West Africa, specifically the 2013-16 Ebola Virus Outbreak, shed light on the many limitations of current surveillance and diagnostics in the region’s public health systems. Tools for rapid, accurate
The long-term vision of the Collaborative Centre (CC) is to build sustainable capacity in Africa for research that leads to an understanding of the interplay between genetic, epigenetic and
Sickle cell disease (SCD) is the commonest genetic disorder in the World. It is most prevalent in Africa. We have established SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa to build capacity locally to enable African scientists study genomics of SCD on the continent